🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Long-Term Prostate Cancer Outcomes Worse With HIFU vs RP bit.ly/2BdvCLu

Join Dr. Brian Helfand for Active Surveillance & Beyond, the second of 4 webinars for men with #prostatecancer. In this Sep 29th webinar, Dr. Helfand talks about genomic and #genetictesting for the #activesurveillance community. REGISTER: bit.ly/3f3J8Tq AnCan Foundation #PCAM

Time running out, but a few seats remain for the FREE webinar on genomics and active surveillance on 9/29 at 7 pm eastern featuring Dr. Brian Helfand @NorthShoreWeb . register: https:/ /bit.ly/3f3J8Tq Sponsors below.

Join Dr. Brian Helfand for Active Surveillance & Beyond, the second of 4 webinars for men with #prostatecancer. In this Sep 29th webinar, Dr. Helfand talks about genomic and #genetictesting for the #activesurveillance community. REGISTER: bit.ly/3f3J8Tq AnCan Foundation #PCAM

The judges have selected the two finalists for our top ODR contest. It’s time to vote for the winner! The Grenier family (L) from Minnesota vs the Gordon Family(R) from Alberta. “Retweet” for the Greiner’s entry. “Like” for the Gordon’s entry. Voting ends-6pm today!

Brian Lane is a urologic oncologist, leader within MUSIC, and all-around fantastic human being. He is loved by his family, his collaborators in MUSIC Urology , and his patients. Consider donating to this cause.

NorthShore Urology and GoPath launch ProstateNow genetic test, including Genetic Risk Score, for individualized prostate cancer risk

We are excited to share our new work relating to inflammation and the prostate: nature.com/articles/s4146… We have a great collaborative team! Simon Hayward @NadiaAtallah1 Kent L. Nastiuk Alex Glaser Brian Helfand MD, PhD Zhang Renyuan NorthShoreUrology *Tweetorial to follow*

📣 Dr. John Hollingsworth (John Hollingsworth) joins @NorthShoreWeb as Chief of Acute Care Quality and Patient Safety! He joins us from the University of Michigan Medical School and School of Public Health and brings renowned expertise in stone management and #HealthServicesResearch

Blue Earth Diagnostics announces efficacy and safety results from phase 3 #LIGHTHOUSE trial of investigational PET imaging agent 18F-rhPSMA-7.3 in newly diagnosed #ProstateCancer. #ReadNow details on UroToday > bit.ly/3EXuv37 #SUO22 Brian F. Chapin

With shifting demographics 📈and a shortage of urologists 📉 we desperately need new innovative medical treatments for #BPH. Excited for the opportunity to move this forward!🔬

Advanced planning session in Montreal. The future projects and research of Aquablation. Thanks to Dr. Kevin Zorn and his team Dr_KevinZorn Alex Glaser PROCEPT BioRobotics montreal